布加替尼是一种激酶抑制剂适用为有间变性淋巴瘤激酶(ALK)-阳性转移非小细胞肺癌(NSCLC)患者且对用克唑替尼[crizotinib]已进展或是不能耐受患者的治疗。
相关产品
¥1,215.00
≈ ₭3,766,500
≈ ₭3,766,500
0 out of 5
¥2,115.32
≈ ₭6,557,500
≈ ₭6,557,500
0 out of 5
¥2,015.00
≈ ₭6,246,500
≈ ₭6,246,500
0 out of 5
¥245.00
≈ ₭759,500
≈ ₭759,500
0 out of 5
¥3,815.00
≈ ₭11,826,500
≈ ₭11,826,500
0 out of 5
¥1,475.81
≈ ₭4,575,000
≈ ₭4,575,000
0 out of 5
¥100.00
≈ ₭310,000
≈ ₭310,000
0 out of 5
¥196.77
≈ ₭610,000
≈ ₭610,000
0 out of 5












评价
目前还没有评价